Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/1995
03/29/1995CN1100721A Imidazopyridine
03/29/1995CN1100716A Basic ethers and process for the preparation thereof
03/29/1995CN1028024C Method for preparation of tetrazole excitatory amino acid receptor antagonists
03/28/1995US5401879 Antidepressants, intestinal antispasmodic agents
03/28/1995US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments
03/28/1995US5401851 Preparation of proline derivatives
03/28/1995US5401770 Antipruritic agents and antipruritic compositions thereof
03/28/1995US5401765 For treating arthritis, pain and fever
03/28/1995US5401758 For treating ischemia
03/28/1995US5401755 Related to ischemic, hypoxic or anoxic conditions, reducing brain damage
03/28/1995US5401750 Derivatives of substituted imidazol-2-one and process for their preparation
03/28/1995US5401749 Memory enhancers, cholinergic agents
03/28/1995US5401748 2,14-disubstituted ergolines, their production and use in pharmaceutical compositions
03/28/1995US5401744 Useful hemi-hydrate form of a cerebral function enhancing agent
03/28/1995US5401743 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof
03/28/1995US5401738 Benzimidazole compounds
03/28/1995CA1334968C Aminoalkylthio derivatives of triazolopyridine or triazoloquinoline, the processes for their preparation, and drugs, useful especially as analgesics, in which they are present
03/28/1995CA1334967C Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
03/25/1995CA2132509A1 Treatment of anxiety with the aid of (s)-(-)-.alpha.- ethyl-2-oxo-1-pyrrolidineacetamide
03/23/1995WO1995007921A1 Chemical compounds, their preparation and use
03/23/1995WO1995007911A1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY
03/23/1995WO1995007908A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
03/23/1995WO1995007906A1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
03/23/1995WO1995007905A1 Optically active imidazolidinone derivative and process for producing the same
03/23/1995WO1995007904A1 Imidazolone and oxazolone derivatives as dopamine antagonists
03/23/1995WO1995007899A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same
03/23/1995WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof
03/23/1995WO1995007893A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/23/1995WO1995007886A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists
03/23/1995WO1995007709A1 Remedy for cranial nerve disorder
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm
03/23/1995WO1995005364A3 Inhibitors of biogenic amine transporters
03/23/1995CA2172163A1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
03/23/1995CA2171940A1 Chemical compounds, their preparation and use
03/23/1995CA2171756A1 Succinamic acid compound, production method thereof and use thereof
03/23/1995CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995CA2168740A1 Imidazolone and oxazolone derivatives as dopamine antagonists
03/23/1995CA2168739A1 Fused tricyclic heteroaromatic derivatives
03/23/1995CA2132568A1 Pharmaceutical compositions and usages
03/22/1995EP0644194A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof
03/22/1995EP0644187A1 Antimigraine cyclobutenedione derivatives of tryptamines
03/22/1995EP0643968A1 Molded pharmaceutical form for oral delivery of acetylsalicyclic acid or its salts and method to prepare it
03/22/1995EP0643962A1 New galenic dosage form for phloroglucinol
03/22/1995EP0643780A1 Multiple solvent cleaning system.
03/22/1995EP0643690A1 Desferrioxamine-b salts and their use as orally effective iron chelators
03/22/1995EP0643688A1 Substituted (arylalkoxybenzyl)aminopropanamide derivatives, their preparation and use as anti-epileptic, neuroprotective and antidepressant agents
03/22/1995EP0643686A1 New compounds
03/22/1995EP0301087B1 Peptide
03/22/1995CN1100424A Pyridoindolobenzodiazepines and derivatives as antipsychotics
03/22/1995CN1100408A Pentanoic acid derivatives
03/22/1995CN1100327A Use of VIP, analogues and fragments thereof for the treatment of neurodegenerative diseases
03/21/1995US5399696 Excitatory amino acid receptor antagonists; nervous system disorders
03/21/1995US5399693 Substituted piperazine-2-carboxylic acids and derivatives thereof
03/21/1995US5399574 5-hydroxytryptamine agonists; vasoconstrictors
03/21/1995US5399571 Neuroprotective drug
03/21/1995US5399568 Dopamine antagonists
03/21/1995US5399550 Physiologically active substance derived or malt and process for the production thereof
03/21/1995CA1334828C Process for the preparation of a powdered extract of valerian roots
03/21/1995CA1334827C (s)-emopamil for the treatment of migraine
03/17/1995CA2130519A1 Antimigraine cyclobutenedione derivatives of tryptamines
03/17/1995CA2130078A1 Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
03/16/1995WO1995007294A1 Pseudo- and non-peptide bradykinin receptor antagonists
03/16/1995WO1995007274A1 Bicyclic aromatic compounds as therapeutic agents
03/16/1995WO1995007262A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/16/1995WO1995007103A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995WO1995007098A1 Methods for regulating gastrointestinal motility
03/16/1995WO1995007091A1 Uses of vegetable oils
03/16/1995WO1995007079A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
03/16/1995WO1995007078A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995WO1995007023A1 Method and composition for the treatment of apathy-amotivation syndrome
03/16/1995WO1995003050A3 Improved nicotine lozenge and therapeutic method for smoking cessation
03/16/1995WO1995002051A3 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
03/16/1995CA2171440A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995CA2171198A1 Method and composition for the treatment of apathy-amotivation syndrome
03/16/1995CA2170488A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995CA2170056A1 1,4-benzodioxane derivatives for treating cns disorders
03/16/1995CA2168738A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/15/1995EP0642788A2 Tramadol salt containing medicaments with sustained release of the active ingredient
03/15/1995EP0642787A2 Cessation of tobacco use
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642508A1 Tricyclic quinoxalinediones as glutamate receptor antagonists
03/15/1995EP0642504A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
03/15/1995EP0642497A1 Novel n-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives
03/15/1995EP0642496A1 Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0642336A1 Use of nsiad in the treatment of dementia
03/15/1995EP0642335A1 Controlled release preparation containing a salt of morphine
03/15/1995EP0563153B1 N-(mercaptoalkyl)amides
03/15/1995EP0526478B1 3-indolyl thioacetate derivatives
03/15/1995CN1100096A Process for the preparation of 2-Û4-|4(4-chloro-1-pyrazolyl)butyl¨1-piperazinylÙ pyrimidine (lesopitron)
03/15/1995CN1027895C Method for preparation and purification of mixture of glycosphingolipids free from contamination by non-conventional viruses
03/15/1995CN1027892C Improved process for preparation of substituted indolone derivatives
03/15/1995CA2131967A1 Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
03/15/1995CA2131966A1 Substituted 6,11-ethano-6,11-dihydrobenzo(b)quinolizinium salts and compositions and methods of use thereof
03/15/1995CA2128275A1 12-hetero substituted 6,11-ethano-6,11-dihydrobenzo¬b| quinolizinium salts and compositions and method of use thereof
03/14/1995US5397800 Gastrointestinal disorders
03/14/1995US5397799 Anxiolytic agents, antidepressants
03/14/1995US5397797 Treatment of ocular hypertension with an ocular synergistic combination
1 ... 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 ... 1833